Paychex (NASDAQ: PAYX) recently received a number of ratings updates from brokerages and research firms: 4/7/2026 – Paychex had its price target lowered by TD Cowen from $95.00 to $94.00. They now have a “hold” rating on the stock. 3/27/2026 – Paychex was upgraded by Argus to “strong-buy”. 3/26/2026 – Paychex had its price target […]

A number of firms have modified their ratings and price targets on shares of Medtronic (NYSE: MDT) recently: 4/7/2026 – Medtronic had its price target lowered by Citigroup Inc. from $117.00 to $110.00. They now have a “buy” rating on the stock. 4/6/2026 – Medtronic had its price target lowered by Evercore Inc from $115.00 […]

Several analysts have recently updated their ratings and price targets for Cleveland-Cliffs (NYSE: CLF): 4/6/2026 – Cleveland-Cliffs was upgraded by Argus to “hold”. 4/1/2026 – Cleveland-Cliffs is now covered by The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $9.00 price target on the stock. 3/25/2026 – Cleveland-Cliffs is now covered by […]

Several brokerages have updated their recommendations and price targets on shares of Generac (NYSE: GNRC) in the last few weeks: 4/1/2026 – Generac had its price target raised by Canaccord Genuity Group Inc. from $275.00 to $300.00. They now have a “buy” rating on the stock. 3/27/2026 – Generac had its price target raised by […]

A number of firms have modified their ratings and price targets on shares of ServiceNow (NYSE: NOW) recently: 4/7/2026 – ServiceNow had its price target lowered by The Goldman Sachs Group, Inc. from $216.00 to $188.00. They now have a “buy” rating on the stock. 4/7/2026 – ServiceNow had its price target lowered by BTIG […]

Entrada Therapeutics (NASDAQ: TRDA) has recently received a number of price target changes and ratings updates: 4/6/2026 – Entrada Therapeutics had its price target raised by Oppenheimer Holdings, Inc. from $21.00 to $23.00. They now have an “outperform” rating on the stock. 4/1/2026 – Entrada Therapeutics is now covered by Cantor Fitzgerald. They set an […]